Chemoinformatics and nutrition (QiN)

INFECTION, IMMUNITY AND ENVIRONMENT
TARGETS

The main objective of the Chemoinformatics and Nutrition research group is the identification of bioactive molecules in molecular databases that can be used in the development of medical applications (treatment of diabetes mellitus, chronic inflammation, antivirals, anticancer, etc.) as well as skin cosmetics, self-tanning, etc.) or functional food (prevention of diabetes mellitus and chronic inflammation). To achieve these objectives we use computational tools of our own creation as well as those of others.

RESPONSIBLE
  • Santiago García-Vallvé

  • Presentation
  • Lines of research
  • Members
  • Competitive projects
  • No competitives projects
  • Publications
  • Doctoral theses
  • Innovation and transfer

The Chemoinformatics and Nutrition (QiN) research group uses computational tools to identify bioactive molecules with medical, cosmetic and nutritional applications. Its main lines include the search for antivirals (SARS-CoV-2, Dengue, Zika), anticancer (for head and neck cancer) and collaboration with other scientific groups.

He is also working on the development of natural depigmenting products, bioactive peptides and enzyme inhibitors such as protease of SARS-CoV-2. therapeutics.

  • Search for antivirals against SARS-CoV-2, Dengue and Zika.
  • Search for anticancer drugs in head and neck cancer (project carried out in collaboration with the research group “Head and neck cancer: Biomedical Research in Tumor Stem Cells” of the VHRI and the “Medicinal Chemistry & Synthesis” of the CSIC).
  • Search for drugs for the treatment of Alzheimer’s disease (in collaboration with the research groups of Dr. Cristina Malagelada and “Medicinal Chemistry and Pharmacology of Neurodegenerative diseases” of the UB).

    Last five years

  • Title: Desarrollo de nuevas herramientas computacionales para el descubrimiento de fármacos contra las pandemias actuales y futuras (NEXT-PANDEMICS)

    Principal Investigator: Santiago Garcia Vallvé i Francesc d’Assís Serratosa Casanelles

    Collaborating researchers: Gerard Pujadas Anguiano, Maria Carmen Julià Ferré, Susana Maria Alvarez Fernandez

    File code: PID2022-138327OB-I00

    Amount: 45.000€

    Start date: 01/09/2023

    End date: 31/08/2026

    Funding agency: MINISTERIO DE CIENCIA Y INNOVACION

  • Title: Quimioinformàtica i Nutrició

    Principal Investigator: Gerard Pujadas Anguiano

    Collaborating researchers: Santiago Garcia Vallvé, Pere Puigbò Avalos, Bryan Percy Saldivar Espinoza i Guillem Macip Sancho

    File code: 2021 SGR 00031

    Amount: 0€

    Start date: 01/01/2022

    End date: 30/06/2025

    Funding agency: AGENCIA DE GESTIO D’AJUTS UNIVERSITARIS

  • Title: Aproximació tècnica integrada pel descobriment de nous compostos bioactius amb propietats beneficioses per la salut cutània.

    Principal Investigator: Miquel Mulero Abellán

    Collaborating researchers: Gerard Pujadas Anguiano, Santiago Garcia Vallvé, Begoña Muguerza

    File code: R2B2023/06

    Amount: 10.000 €

    Start date: 12/04/2023

    End date: 31/12/2023

    Funding agency: Fundació URV

  • Title: PEPTIDEGO: Una plataforma bioinformàtica per la valorització i el guiatge en l’obtenció en condicions industrials de pèptids bioactius procedents de subproductes i excedents de la indústria agroalimentària.

    Principal Investigator: Gerard Pujadas Anguiano

    Collaborating researchers: Santiago Garcia Vallvé, Adrià Cereto-Massagué

    File code: R2B2022/06

    Amount: 10.000 €

    Start date: 12/04/2022

    End date: 31/12/2022

    Funding agency: Fundació URV

    Last five years

  • Title: ESTUDIO BIOCOMPUTACIONAL PARA IDENTIFICAR LAS DIANAS MOLECULARES DEL EFECTO ANTIMICROBIANO DE LOS PRODUCTOS DE OHWHITE

    Principal Investigator: Gerard Pujadas

    Collaborating researchers: Santi Garcia-Vallvé, Aleix Gimeno Vives

    Type of project: Contracte de transferència

    Amount: 15.000,00€

    Start date: 14/01/2025

    End date: 31/12/2025

    Funding agency: Fundació Eurecat

  • Title: ESTUDIO IN SILICO PARA OPTIMIZAR LA UTILIZACION DEL PRODUCTO SANIDERMIX

    Principal Investigator: Gerard Pujadas

    Collaborating researchers: Santi Garcia-Vallvé, Aleix Gimeno Vives

    Type of project: Contracte de transferència

    Amount: 15.000,00€

    Start date: 25/10/2024

    End date: 24/10/2025

    Funding agency: Fundació Eurecat

  • Title: DESENVOLUPAMENT I MILLORA DE LA PLATAFORMA BIOINFORMATICA PEPTIDEGO

    Principal Investigator: Gerard Pujadas

    Collaborating researchers: Santi Garcia-Vallvé, Adrià Cereto-Massagué

    Type of project: Contracte de transferència

    Import: 4.500,00€

    Start date: 04/04/2022

    End date: 03/06/2022

    Funding agency: Fundació Eurecat

  • Title: DISEÑO Y DESARROLLO DE UN NOVEDOSO PRODUCTO DESPIGMENTANTE A PARTIR DE INGREDIENTES NATURALES QUE ATACA NUEVAS Y MÚLTIPLES DIANAS

    Principal Investigator: Gerard Pujadas

    Collaborating researchers: Santi Garcia-Vallvé

    Type of project: Contracte de transferència

    Amount: 40.000,00€

    Start date: 01/01/2021

    End date: 31/03/2022

    Funding agency: Bella Aurora S.A.

    Articles published in indexed journals, including IF and quartile, last 5 years

  • Title: SARS-CoV-2 main protease (M-pro) mutational profiling: An insight into mutation coldspots

    Authors: Pol Garcia-Segura, Ariadna Llop-Peiró, Nil Novau-Ferré, Júlia Mestres-Truyol, Bryan Saldivar-Espinoza, Gerard Pujadas, Santiago Garcia-Vallvé

    Magazine title: Computers in Biology and Medicine

    Year of publication: 2025

    Volume, pages: 184:109344

    FI: 7.0

    Quartile: Q1 Biology

  • Title: Are protein-ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?

    Authors: Ariadna Llop-Peiró, Guillem Macip, Santiago Garcia-Vallvé, Gerard Pujadas

    Magazine title: Drug Discov Today

    Year of publication: 2024

    Volume, pages: 29(10):104137

    FI: 6.5

    Quartile: Q1 PHARMACOLOGY & PHARMACY

  • Title: Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor

    Authors: Timoteo Delgado-Maldonado, Alonzo González-González, Adriana Moreno-Rodríguez, Virgilio Bocanegra-García, Ana Verónica Martinez-Vazquez, Erick de Jesús de Luna-Santillana, Gerard Pujadas, Guadalupe Rojas-Verde, Edgar E Lara-Ramírez, Gildardo Rivera

  • Magazine title: Pharmaceutics

    Year of publication: 2024

    Volume, pages: 16(5):613

    FI: 4.9

    Quartile: Q1 PHARMACOLOGY & PHARMACY

  • Title: Challenges in distinguishing functional proteins from polyproteins in databases: implications for drug discovery

    Authors: Ariadna Llop-Peiró, Gerard Pujadas, Santiago Garcia-Vallvé

    Magazine title: Briefings in Bioinformatics

    Year of publication: 2024

    Volume, pages: 25(2):bbae012

    FI: 6.8

    Quartile: Q1 BIOCHEMICAL RESEARCH METHODS

  • Title: Identification of N-Acyl Hydrazones as New Non-Zinc-Binding MMP-13 Inhibitors by Structure-Based Virtual Screening Studies and Chemical Optimization

    Authors: Doretta Cuffaro, Aleix Gimeno, Bianca Laura Bernardoni, Riccardo Di Leo, Gerard Pujadas, Santiago Garcia-Vallvé, Susanna Nencetti, Armando Rossello, Elisa Nuti

    Magazine title: International Journal Of Molecular Sciences

    Year of publication: 2023

    Volume, pages: 24(13):11098

    FI: 5.6

    Quartile: Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

  • Title: The Mutational Landscape of SARS-CoV-2

    Authors: Bryan Saldivar-Espinoza, Pol Garcia-Segura, Nil Novau-Ferré, Guillem Macip, Rubén Martínez, Pere Puigbò, Adrià Cereto-Massagué, Gerard Pujadas, Santiago Garcia-Vallvé

    Magazine title: International Journal Of Molecular Sciences

    Year of publication: 2023

    Volume, pages: 24(10):9072

    FI: 5.6

    Quartile: Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

  • Title: Drug Potency Prediction of SARS-CoV-2 Main Protease Inhibitors Based on a Graph Generative Model

    Authors: Sarah Fadlallah , Carme Julià, Santiago García-Vallvé, Gerard Pujadas, Francesc Serratosa

    Magazine title: International Journal Of Molecular Sciences

    Year of publication: 2023

    Volume, pages: 24(10):8779

    FI: 5.6

    Quartile: Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

  • Title: Recent advances in the development of methyltransferase (MTase) inhibitors against (re)emerging arboviruses diseases dengue and Zika

    Authors: Delgado-Maldonado T; Moreno-Herrera A; Pujadas G; Vázquez-Jiménez LK; González-González A; Rivera G

    Magazine title: European Journal Of Medicinal Chemistry

    Year of publication: 2023

    Volume, pages: 252 115290-

    FI: 7.088

    Quartile: Q1 Chemistry, Medicinal

  • Title: Prediction of Recurrent Mutations in SARS-CoV-2 Using Artificial Neural Networks

    Authors: Saldivar-Espinoza, Bryan; Macip, Guillem; Garcia-Segura, Pol; Mestres-Truyol, Julia; Puigbo, Pere; Cereto-Massague, Adria; Pujadas, Gerard; Garcia-Vallve, Santiago

    Magazine title: International Journal Of Molecular Sciences

    Year of publication: 2022

    Volume, pages: 23(23):14683.

    FI: 6.208.

    Quartile: Q1 Chemistry, Multidisciplinary.

  • Title: A review of the current landscape of SARS-CoV-2 main protease inhibitors: Have we hit the bullseye yet?

    Authors: Macip G; Garcia-segura P; Mestres-truyol J; Saldivar-espinoza B; Pujadas G; Garcia-Vallvé S

    Magazine title: International Journal Of Molecular Sciences

    Year of publication: 2022

    Volume, pages: 23(1):259

    FI: 6.208.

    Quartile: Q1 Chemistry, Multidisciplinary.

  • Title: Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition

    Authors: Macip, Guillem; Garcia-Segura, Pol; Mestres-Truyol, Julia; Saldivar-Espinoza, Bryan; Ojeda-Montes, Maria Jose; Gimeno, Aleix; Cereto-Massague, Adria; Garcia-Vallve, Santiago; Pujadas, Gerard

    Magazine title: Medicinal Research Reviews

    Year of publication: 2022

    Volume, pages: 42(2):744-769

    FI: 12.388

    Quartile: Q1 Pharmacology & Pharmacy

  • Title: Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening

    Authors: Gimeno, Aleix; Cuffaro, Doretta; Nuti, Elisa; Ojeda-Montes, Maria Jose; Beltran-Debon, Raul; Mulero, Miquel; Rossello, Armando; Pujadas, Gerard; Garcia-Vallvé

    Magazine title: Molecules

    Year of publication: 2021

    Volume, pages: 26(15):4553

    FI: 4.927

    Quartile: Q2 Chemistry, Multidisciplinary

  • Title: Anti‐inflammatory and immunomodulatory effects of the grifola frondosa natural compound o‐orsellinaldehyde on lps‐challenged murine primary glial cells. Roles of NF‐κβ and MAPK

    Authors: Tomas‐hernandez S; Blanco J; Garcia‐Vallvé S; Pujadas G; Ojeda‐montes MJ; Gimeno A; Arola L; Minghetti L; Beltrán‐debón R; Mulero M

    Magazine title: Pharmaceutics

     

    Year of publication: 2021

    Volume, pages: 13(6):806

    FI: 6.525

    Quartile: Q1 Pharmacology & Pharmacy

  • Title: Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition

    Authors: Gimeno A; Mestres-Truyol J; Ojeda-Montes MJ; Macip G; Saldivar-Espinoza B; Cereto-Massagué A; Pujadas G; Garcia-Vallvé S

    Magazine title: International Journal Of Molecular Sciences

    Year of defense: 2020

    Volume, pages: 21(11):3793

    FI: 5.924

    Quartile: Q1 Biochemistry & Molecular Biology

  • Title: Understanding the variability of the S1′ pocket to improve matrix metalloproteinase inhibitor selectivity profiles

    Authors: Gimeno A, Beltrán-Debón R, Mulero M, Pujadas G, Garcia-Vallvé S

     

    Magazine title: Drug Discovery Today

    Year of publication: 2020

    Volume, pages: 25(1):38-57

    FI: 7.851

    Quartile: Q1 Pharmacology & Pharmacy

  • Title: DISEÑO Y DESARROLLO DE UN NOVEDOSO PRODUCTO DESPIGMENTANTE A PARTIR DE INGREDIENTES NATURALES QUE ATACA NUEVAS Y MÚLTIPLES DIANAS

    Name of doctoral student: TIMOTEO DELGADO MALDONADO

    Year of defense: 2025

     

    University: INSTITUTO POLITÉCNICO NACIONAL (REYNOSA, MÉXICO)

     

  • Title: Application of machine learning methods on SARS-Cov-2: Mortality prediction by using health and nutritional factors and prediction of recurrent mutations

    Name of doctoral student: Bryan Percy Saldivar Espinoza

    Year of defense: 2024

    University: Universitat Rovira i Virgili

  • Title: Studying the limits of protein-ligand docking to predict new non-covalent inhibitors for the SARSCoV-2 main protease

    Name of doctoral student: Guillem Macip Sancho

    Year of defense: 2023

    University: Universitat Rovira i Virgili

  • Title: Identification of protein tyrosine phosphatase 1B and matrix metalloproteinase 13 inhibitors by virtual screening for the treatment of obesity and obesity-associated disorders

     

    Name of doctoral student: Aleix Gimeno Vives

    Year of defense: 2019

    University: Universitat Rovira i Virgili

  • Title: COMPOUNDS FOR USE IN THE TREATMENT OF CANCERS THAT OVEREXPRESS TSPAN1

     

    Applicant:  FUNDACIÓ HOSPITAL UNIVERSITARI VALL D’HEBRON – INSTITUT DE RECERCA

    University: UNIVERSITAT ROVIRA I VIRGILI

     

    Entity: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC)

    Application number: EP23383269.0

    Date of application: 11 de diciembre de 2023

     

    Depository office: Spanish Patent and Trademark Office (OEPM)

     

Team Members

  • Group Managers

    • Santiago García-Vallvé
    • Gerard Pujadas Anguiano
  • Research team

    • Aleix Gimeno Vives
    • Ariadna Llop Peiró